The new EFPIA code on disclosure of transfers of value: a meaningful path to transparency?
This article was originally published in SRA
Vincenzo Salvatore, Hae-Won Min Liao and Catherine Starks discuss the new code.
You may also be interested in...
The Saudi Food and Drug Authority has finalized the details of a new transparency initiative under which drug and medical device companies will have to disclose their financial relationships with healthcare professionals and institutions.
Cosmetics Europe Talks Microplastic: ECHA Frustrations, ‘Value Judgments’ And International Trade Uncertainty
The European Chemicals Agency's microplastic restriction proposal received committee backing in 2020 without changes sought by the cosmetics industry, which faces €15bn in projected costs and scarce alternatives at present. It may come down to EU Member States to decide whether the ECHA restriction proposal is proportionate in balancing environmental goals and socio-economic impacts.
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.